Sánchez-Tilló E, Siles L, de Barrios O, et al.Expanding roles of ZEB factors in tumorigenesis and tumor progression [J]. Am J Cancer Res, 2011, 1(7):897-912
[4]
Drake JM, Strohbehn G, Bair TB, et al. ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells [J]. Mol Biol Cell, 2009, 20: 2207-17.
[5]
Singh M, Spoelstra NS, Jean A, et al. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease [J]. Mod Pathol, 2008, 21: 912-23.
[6]
Bendoraite A, Knouf EC, Garg KS, et al. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition [J].Gynecol Oncol, 2010, 116(1):117-25.
[7]
Burk U, Schubert J, Wellner U, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells [J]. EMBO Rep, 2008 ;9(6):582-9.
[8]
Gregory PA, Bracken CP, Smith E, et al.An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition [J]. Mol Biol Cell, 2011, 22(10):1686-98.
[9]
Peinado H, Olmeda D, Cano A. SNAIL, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype [J].Nat Rev Cancer, 2007, 7: 415-428.
[10]
Takeyama Y, Sato M, Horio M, et al. Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells [J]. Cancer Lett, 2010, 296: 216-224.
[11]
Shih IM, Kurman RJ. Ovarian tumourigenesis: A proposed model based on morphological and molecular genetic analy-sis [J]. Am J Pathol, 2007, 164: 1511-1518.
[12]
Elloul S, Silins I, Trope CG, et al. Expression of E-cadherin transcriptional regulators in ovarian carcinoma [J]. Virchows Arch, 2006, 449: 520 - 528
